Unclaimed
Meghan M. Taylor
Is this your partnering profile? Claim & update it for free.
This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
About
Meghan M. Taylor advances data-driven thoracic oncology care via comparative effectiveness and implementation science, evaluating early detection pathways, multidisciplinary models, and pathology/staging quality to strengthen guideline adherence, expand access, and reduce disparities in community health systems.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
HTA300 Reappraisal Following the Loss of Medicine Patent in HTA Guidelines
2024
Using Virtual Reality in Mental Health Nursing to Improve Behavioral Health Equity
2024
Case Management in Prevention of 30-Day Readmission in Post-Coronary Artery Bypass Graft Surgery
2024
Prospective Comparative Effectiveness Trial of Multidisciplinary Lung Cancer Care Within a Community-Based Health Care System
2022
The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer
2022
P62.05 Identifying Risk-Factors for Lung Cancer Diagnosis After Detection of Incidental Lung Nodules
Journal of Thoracic Oncology
•2021
MA10.02 Lung Cancer Detected By Screening, Incidental Lung Nodule Program and Neither: A Prospective Observational Study
Journal of Thoracic Oncology
•2021
MA17.05 Intrapulmonary Lymph Node (LN) Retrieval With a Novel Gross Dissection Method: A Prospective, Population-Based Cohort Study
Journal of Thoracic Oncology
•2021
Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected NSCLC in a High Mortality Area of the United States
Journal of Thoracic Oncology
•2021
Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System
JTO Clinical and Research Reports
•2021
Early detection of lung cancer with an incidental lung nodule program (ILNP).
2021
Interest in Cessation Treatment Among People Who Smoke in a Community-Based Multidisciplinary Thoracic Oncology Program
JTO Clinical and Research Reports
•2021
MA03.05 Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
•2021
No funding yet
This innovator hasn't added funding yet. In the meantime, you might want to explore their publications, patents, and other profile details.
No patents yet
This innovator hasn't added patents yet. In the meantime, you might want to explore their publications, funding, and other profile details.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.